# Study to Treat Uveitis Associated Macular Edema

> **NCT00114062** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 15 (actual)

## Conditions studied

- Cystoid Macular Edema
- Uveitis

## Interventions

- **DRUG:** denufosol tetrasodium (INS37217) Intravitreal Injection

## Key facts

- **NCT ID:** NCT00114062
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114062, "Study to Treat Uveitis Associated Macular Edema". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00114062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*